Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
SpIntellx
company
About
Shaping the Future of Spatially Intelligent Biology
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $224.99K
- Industries
- Artificial Intelligence,Biopharma,Biotechnology,Life Science,Machine Learning
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
SpIntellx has the first-mover advantage in Precision Pathology and Spatially Intelligent Biology by applying truly unbiased spatial analytics software powered by explainable AI to decipher the complex cancer biology. SpIntellx’s software solutions have the potential to unlock a plethora of new applications in medicine and research by answering the fundamental question “Why?”, thus revealing the underlying patient-specific disease network biology, across each stage of the drug development, diagnostics, and treatment pipelines.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$524.99K
SpIntellx has raised a total of
$524.99K
in funding over 2 rounds. Their latest funding was raised on
Feb 8, 2019 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 8, 2019 | Grant | $224.99K | 1 |
National Science Foundation
|
— | Detail |
| Sep 10, 2018 | Seed | $300K | 1 |
Newlin Investment Company
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
1
0
SpIntellx has made 1 investments. Their most recent investment was on
Nov 28, 2022, when Dwarfs raised €30M.
Investors
Number of Lead Investors
Number of Investors
2
2
SpIntellx is funded by 2 investors.
National Science Foundation
and Newlin Investment Company
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
|
Newlin Investment Company
|
Yes | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
